Sep 25, 2026
Andrew Jallouk, MD, PhD, Assistant Professor of Medicine in the Division of Hematology/Oncology, was lead author of a new study, published Sept. 25 in Cancer Discovery, that reveals key insights into the biological factors shaping efficacy of off-the-shelf CAR-T cell therapies.